American Journal of Cardiovascular Drugs

, Volume 13, Issue 3, pp 163–175

Treatment of Hypertension in Obese Patients

Review Article

DOI: 10.1007/s40256-013-0008-5

Cite this article as:
Kidambi, S. & Kotchen, T.A. Am J Cardiovasc Drugs (2013) 13: 163. doi:10.1007/s40256-013-0008-5


Obesity is a global pandemic and with its rise, its associated co-morbidities are increasing in prevalence, particularly uncontrolled hypertension. Lifestyle changes should be an anchor for the management of obesity-related hypertension; however, they are difficult to sustain. Drug therapy is often necessary to achieve blood pressure control. Diuretics, inhibitors of the renin–angiotensin system, and dihydropyridine calcium channel blockers are often used as first trio, with subsequent additions of mineralocorticoid receptor antagonists and/or dual alpha/beta blocking agents. While a number of agents are currently available, 50 % of hypertensive patients remain uncontrolled. A number of novel drug and invasive therapies are in development and hold significant potential for the effective management of obesity-related hypertension.

Copyright information

© Springer International Publishing Switzerland 2013

Authors and Affiliations

  1. 1.Division of Endocrinology, Metabolism and Clinical NutritionMedical College of WisconsinMilwaukeeUSA
  2. 2.Clement A. Zablocki VA Medical CenterMilwaukeeUSA